Cell cycle regulation and control of angioplasty restenosis

被引:4
|
作者
Welt, FGP
Edelman, ER
机构
[1] Harvard University-Massachusetts I., Div. of Hlth. Sci. and Technology, Cambridge, MA 02139
基金
美国国家卫生研究院;
关键词
angioplasty; cell cycle; restenosis;
D O I
10.1016/S0169-409X(96)00481-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The proliferative response of smooth muscle cells to injury remains the largest cause of clinical failure in interventions aimed at mitigating the effects of the atherosclerotic process. Contributing to this proliferative response are a number of factors including platelet and leukocyte adherence, transmigration, and activation with a concomitant release of a myriad of growth factors and remodelling of the extracellular matrix. The failure of attempts to modify this response by targeting single elements of the process is testimony to the redundancy of proliferative stimuli at work in the restenotic lesion. Therefore, interest has been directed towards the final common pathway of the proliferative vasculopathies, the cell cycle itself. The purpose of this chapter is to summarize recent attempts to control proliferation through interventions aimed at critical elements of the cell cycle, and to comment about how these interventions could be brought to bear in the clinical realm.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [31] Influence of haematological parameters before coronary angioplasty on subsequent restenosis
    Avci, A
    Boyaci, A
    Çagli, K
    Cosgun, A
    Gokce, V
    Duru, E
    Korkmaz, S
    ACTA CARDIOLOGICA, 2004, 59 (03) : 263 - 268
  • [32] Homocysteine and post-angioplasty restenosis
    Ambrosi, P
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2003, 13 (06) : 391 - 397
  • [33] INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION AND EXPERIMENTAL ANGIOPLASTY RESTENOSIS BY BETA-CYCLODEXTRIN TETRADECASULFATE
    HERRMANN, HC
    OKADA, SS
    HOZAKOWSKA, E
    LEVEEN, RF
    GOLDEN, MA
    TOMASZEWSKI, JE
    WEISZ, PB
    BARNATHAN, ES
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06): : 924 - 931
  • [34] RESTENOSIS - THE ACHILLES HEEL OF CORONARY ANGIOPLASTY
    LANGE, RA
    WILLARD, JE
    HILLIS, LD
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 306 (04): : 265 - 275
  • [35] CONSEQUENCES OF RESTENOSIS AFTER CORONARY ANGIOPLASTY
    VLIETSTRA, RE
    HOLMES, DR
    RODEHEFFER, RJ
    BAILEY, KR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1991, 31 (02) : 143 - 147
  • [36] Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty
    Wei, GL
    Krasinski, K
    Kearney, M
    Isner, JM
    Walsh, K
    Andres, V
    CIRCULATION RESEARCH, 1997, 80 (03) : 418 - 426
  • [37] The role of BRCA1 in transcriptional regulation and cell cycle control
    P B Mullan
    J E Quinn
    D P Harkin
    Oncogene, 2006, 25 : 5854 - 5863
  • [38] The role of BRCA1 in transcriptional regulation and cell cycle control
    Mullan, P. B.
    Quinn, J. E.
    Harkin, D. P.
    ONCOGENE, 2006, 25 (43) : 5854 - 5863
  • [39] Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty -: Results of the beta energy restenosis trial (BERT)
    King, SB
    Williams, DO
    Chougule, P
    Klein, JL
    Waksman, R
    Hilstead, R
    Macdonald, J
    Anderberg, K
    Crocker, IR
    CIRCULATION, 1998, 97 (20) : 2025 - 2030
  • [40] LOW-MOLECULAR-WEIGHT HEPARIN IN PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY - RESULTS OF ENOXAPARIN RESTENOSIS (ERA) TRIAL
    FAXON, DP
    SPIRO, TE
    MINOR, S
    COTE, G
    DOUGLAS, J
    GOTTLIEB, R
    CALIFF, R
    DOROSTI, K
    TOPOL, E
    GORDON, JB
    OHMEN, M
    RAIZNER, A
    PAR, T
    CURRIER, J
    HANKIN, B
    CIRCULATION, 1994, 90 (02) : 908 - 914